Article
Crosstalk between Ca2+ Signaling and Cancer Stemness: The Link to Cisplatin Resistance
14 Sept 2022
Abstract excerpt
In the fight against cancer, therapeutic strategies using cisplatin are severely limited by the appearance of a resistant phenotype. While cisplatin is usually efficient at the beginning of the treatment, several patients endure resistance to this agent and face relapse. One of the reasons for this resistant phenotype is the emergence of a cell subpopulation known as cancer stem cells (CSCs). Due to their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
